Skip to main content

Advertisement

Log in

Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background and Aims

Novel endoscopic procedures (endoscopic sleeve gastroplasty (ESG), AspireAssist (AA), and primary obesity surgery endolumenal (POSE)) have been developed for treatment of obesity. We aimed to conduct a systematic review and meta-analysis to evaluate and compare the efficacy of these three endoscopic procedures.

Methods

Main outcomes of interest were percent excess weight loss (%EWL) and percent total body weight loss (%TBWL). Weighted pooled means (WPMs) were calculated and analyzed using random effects model. Mean differences (MDs) were calculated to compare these procedures.

Results

Twelve studies with 1149 patients were included. WPMs for %EWL at 6 and 12 months with ESG were 49.67 (45.67, 53.66) and 52.75 (43.52, 61.98), respectively, while %TBWLs at 6 and 12 months with ESG were 16.01 (15.10, 16.92) and 17.41 (17.08, 17.74), respectively. WPMs for %EWL at 6 and 12 months with POSE were 43.79 (40.17, 47.42) and 44.91 (40.90, 48.92), respectively. WPM for %EWL at 12 months with AA was 50.85 (46.03, 55.68). While comparing ESG and POSE, at 6 months and 12 months, MD for %EWL was 6.17 (1.07, 11.26; P = 0.01) and 7.84 (− 2.05, 17.71; P = 0.06) in favor of ESG. No difference in %EWL was observed while comparing ESG with AA (P = 0.29). Likewise, MD for %EWL to compare AA and POSE was not significant (P = 0.68).

Conclusions

During a follow-up of 6–12 months, both AA and ESG had excellent efficacy in achieving significant and sustained weight loss; however, ESG was found to be superior in terms of weight loss when compared with POSE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. World Health Organization. Obesity and overweight - fact sheet no. 312. Updated March 2013. www.who.int/mediacentre/factsheets/fs311/en/. Accessed 2 July 2018.

  2. Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284–91.

    Article  CAS  PubMed  Google Scholar 

  3. CDC. Adult obesity causes & consequences. https://www.cdc.gov/obesity/adult/causes.html. Accessed 2 July 2018.

  4. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv

    Article  CAS  PubMed  Google Scholar 

  5. Karlsson J, Taft C, Ryden A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31(8):1248–61.

    Article  CAS  Google Scholar 

  6. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  CAS  PubMed  Google Scholar 

  7. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Griffith PS, Birch DW, Sharma AM, et al. Managing complications associated with laparoscopic Roux-en-Y gastric bypass for morbid obesity. Can J Surg. 2012;55(5):329–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA. 2014;311(1):23–4.

    Article  CAS  PubMed  Google Scholar 

  10. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159–91.

    Article  PubMed  Google Scholar 

  11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.

    Article  CAS  PubMed  Google Scholar 

  13. DG HJA. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions 2008;Version 5.0.1.

  14. NIH. Quality assessment tool for before-after studies with no control group. National Institutes of Health Web site; 2014. http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/before-after. Accessed 2 July 2018.

  15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  16. Sullivan S, Stein R, Jonnalagadda S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145(6):1245–52. e1-5

    Article  PubMed  Google Scholar 

  17. Noren E, Forssell H. Aspiration therapy for obesity; a safe and effective treatment. BMC Obes. 2016;3:56.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112(3):447–57.

    Article  PubMed  Google Scholar 

  19. Machytka EF H, Testoni P, Janssen I, et al. Aspiration therapy as a tool to treat obesity: one to four year results in a 160-patient multicenter post market registry study. Surg Obes Relat Dis. 2017;13:S57.

    Article  Google Scholar 

  20. Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37–43 e1.

    Article  PubMed  Google Scholar 

  21. Lopez-Nava G, Galvao MP, Bautista-Castano I, et al. Endoscopic sleeve gastroplasty for obesity treatment: two years of experience. Arq Bras Cir Dig. 2017;30(1):18–20.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017;15(4):504–10.

    Article  PubMed  Google Scholar 

  23. Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc. 2018;32(4):2159–64.

  24. Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity (Silver Spring). 2017;25(2):294–301.

    Article  Google Scholar 

  25. Miller K, Turro R, Greve JW, et al. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy. Obes Surg. 2017;27(2):310–22.

    Article  PubMed  Google Scholar 

  26. Lopez-Nava G, Bautista-Castano I, Jimenez A, et al. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2015;11(4):861–5.

    Article  PubMed  Google Scholar 

  27. Espinos JC, Turro R, Mata A, et al. Early experience with the incisionless operating platform (IOP) for the treatment of obesity : the primary obesity surgery endolumenal (POSE) procedure. Obes Surg. 2013;23(9):1375–83.

    Article  CAS  PubMed  Google Scholar 

  28. Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg. 2017;27(10):2649–55.

    Article  PubMed  Google Scholar 

  29. Lopez-Nava G, Galvao MP, da Bautista-Castano I, et al. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015;47(5):449–52.

    PubMed  Google Scholar 

  30. Breviere GLN, Bautista-Castano I, Fernandez-Corbelle JP, et al. Endoscopic sleeve gastroplasty (Apollo method): new approach in the treatment of obesity. Rev Esp Enferm Dig. 2016;108(4):201–6.

    Google Scholar 

  31. Lopez-Nava G, Galvao M, Bautista-Castano I, et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016;4(2):E222–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Lopez-Nava G, Galvao M, Bautista-Castaño I, et al. First results after endoscopic sleeve gastroplasty with a follow up time of 6 months. Obes Surg. 2014;24(8):1311–2.

    Google Scholar 

  33. Kumar N, Lopez-Nava G, Nicolle Peña Sahdala H, et al. Endoscopic sleeve gastroplasty: multicenter weight loss results. Gastroenterology. 2015;148(4):S179.

    Article  Google Scholar 

  34. Kumar N, Sahdala HNP, Shaikh S, et al. Endoscopic sleeve gastroplasty for primary therapy of obesity: initial human cases. Gastroenterology. 2014;146(5):S571–S2.

    Article  Google Scholar 

  35. Abu Dayyeh BK, Acosta A, Topazian M, et al. One-year follow-up and physiological alterations following endoscopic sleeve gastroplasty for treatment of obesity. Gastroenterology. 2015;148(4):S11–S2.

    Article  Google Scholar 

  36. Lopez-Nava G, Manoel GN. Endoscopic sleeve gastroplasty using a modified plication method for weight loss. Gastrointest Endosc. 2014;79(5):AB362–AB3.

    Article  Google Scholar 

  37. Lopez-Nava G, Neto Manoel G, Bautista-Castaño I, et al. First prospective endoscopic sleeve gastroplasty study at 1 year of follow up. Gastroenterology. 2015;148(4):S900–S1.

    Article  Google Scholar 

  38. Lopez-Nava G, Sharaiha RZ, Galvao Neto M, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology. 2016;150(4):S26.

    Article  Google Scholar 

  39. Machytka E, Turro R, Huberty V, et al. Aspiration therapy in super obese patients-pilot trial. Gastroenterology. 2016;150(4):S822–S3.

    Article  Google Scholar 

  40. Therapy AATFoEB, Ginsberg GG, Chand B, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74(5):943–53.

    Article  Google Scholar 

  41. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;(8):CD003641.

  42. Multicenter ESG Trial (MERIT): ClinicalTrials.gov Identifier: NCT03406975; 2018. https://clinicaltrials.gov/ct2/show/NCT03406975.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reem Z. Sharaiha.

Ethics declarations

Disclosures and Conflict of Interest

Reem Z. Sharaiha is a consultant of BSC and Apollo Endosurgery. All other authors have no financial disclosures or conflicts of interest relevant to this study.

Ethical Approval

Systematic review and meta-analysis does not require formal consent.

Informed Consent

Informed consent does not apply to this systematic review and meta-analysis.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix. Quality assessment of studies with NIH Quality assessment tool for before–after studies with no control group

Appendix. Quality assessment of studies with NIH Quality assessment tool for before–after studies with no control group

Criteria

Noren (2016)

Machytka (2017)

Abu Dayyeh (2017)

Lopez (2017)

Sharaiha (2017)

Kumar (2017)

Lopez (2014)

Espinos (2013)

1. Was the study question or objective clearly stated?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

2. Were eligibility/selection criteria for the study population prespecified and clearly described?

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

3. Were the participants in the study representative of those who would be eligible for the test/service/intervention in the general or clinical population of interest?

Yes

N/A

Yes

Yes

Yes

Yes

Yes

Yes

4. Were all eligible participants that met the prespecified entry criteria enrolled?

Yes

N/A

Yes

Yes

Yes

Yes

Yes

Yes

5. Was the sample size sufficiently large to provide confidence in the findings?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

6. Was the test/service/intervention clearly described and delivered consistently across the study population?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

7. Were the outcome measures prespecified, clearly defined, valid, reliable, and assessed consistently across all study participants?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

8. Were the people assessing the outcomes blinded to the participants’ exposures/interventions?

No

No

No

No

No

No

No

No

9. Was the loss to follow-up after baseline 20% or less? Were those lost to follow-up accounted for in the analysis?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10. Did the statistical methods examine changes in outcome measures from before to after the intervention? Were statistical tests done that provided p values for the pre-to-post changes?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

11. Were outcome measures of interest taken multiple times before the intervention and multiple times after the intervention?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Result

Good

Fair

Good

Good

Good

Good

Good

Good

NIH, National Institutes of Health; N/A, not applicable

Quality assessment of randomized controlled trial using Cochrane tool for assessing risk of bias

 

Selection bias

Performance bias

Detection bias

Attrition bias

Reporting bias

Other bias

 

Sullivan (2017)

Low risk

High risk

Low risk

Low risk

Low risk

Low risk

 

Miller (2017)

Low risk

High risk

High risk

Low risk

Low risk

Low risk

 

Sullivan (2013)

Low risk

High risk

High risk

Low risk

Low risk

Low risk

 

Thompson (2017)

Low risk

High risk

High risk

Low risk

Low risk

Low risk

 

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, Z., Khan, M.A., Hajifathalian, K. et al. Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal. OBES SURG 29, 2287–2298 (2019). https://doi.org/10.1007/s11695-019-03865-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-019-03865-w

Keywords

Navigation